share_log

6-K: Gsk Presents Positive Data for Arexvy, Its Respiratory Syncytial Virus (Rsv) Vaccine, Indicating Protection over Three Rsv Seasons

6-K: Gsk Presents Positive Data for Arexvy, Its Respiratory Syncytial Virus (Rsv) Vaccine, Indicating Protection over Three Rsv Seasons

6-K:GSK提供积极的数据对于Arexvy,其呼吸道合胞病毒(RSV)疫苗,表示在三个RSV季节内提供保护
美股SEC公告 ·  10/08 09:26
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息